Musings from The Power List: Laura Carbonell Rozas

• October 29, 2026

FDA expands talazoparib use in prostate cancer

The combination with enzalutamide reduced the risk of radiographic progression or death by 52% .

• by Mouj Hijazi

• October 27, 2026

• 3 min

Response to Zhou and Shan: Interpreting long-term response to rituximab in immune thrombocytopenia

• by Galina Tsykunova, Eskild Bendix Kristiansen, Tor Henrik Anderson Tvedt, Henrik Frederiksen, Christian Fynbo Christiansen, Marie Linder, Shahram Bahmanyar, Waleed Ghanima

• October 27, 2026

Inside the Brain’s Hidden Lipid Map

Spatial mass spectrometry reveals how 172 lipids vary across brain regions, cell types, and physiological states

• October 29, 2026

• 3 min